Improving Health of Canadians the Focus in Wide-Ranging Health Talks

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan 20, 2016) -

For Immediate Release
2016HLTH0003-000062
Jan. 20, 2016

Ministry of Health

NEWS RELEASE

Improving health of Canadians the focus in wide-ranging health talks

(disponible en français en bas de page)

VANCOUVER - In a wide-ranging set of discussions touching on many aspects of Canadians' health and health care, provincial and territorial health ministers committed to continued cooperation and collaboration across the country during a meeting today in Vancouver.

"My colleagues and I looked at the challenges and opportunities faced by provinces and territories in delivering health services across the country. We know we need to work closely together as we continue to improve our systems," said B.C. Health Minister Terry Lake, who chaired the meeting. "We look forward to our discussions with federal Health Minister Dr. Jane Philpott tomorrow, as we build a new relationship between governments for the benefit of the country's health-care systems and Canadians."

The provinces and territories discussed a new way forward on health care in Canada. The ministers agree that Canadians expect their governments to work together when it comes to health care, within their areas of responsibility, and with flexibility to address the challenges unique to each province and territory. This will be discussed during tomorrow's meeting, including how a long-term federal funding agreement, of at least 25% of all health care spending by provinces and territories, would help support investments in innovation and transformation of health care systems, to improve outcomes for patients.

Many of today's discussions furthered work which began out of the previous meeting of provincial and territorial ministers of health and wellness in September 2014.

Pharmaceuticals

Expensive drugs for rare diseases, also known as orphan drugs, are used to treat life-threatening, chronic and seriously debilitating rare diseases. The cost of these medications continues to put significant pressure on health spending. The ministers affirm that strong, long-term solutions are needed to address the ongoing challenges.

A working group led by B.C., Alberta and Ontario studied the issue of expensive drugs for rare diseases, looking at issues of access, evidence of effectiveness, communication with doctors and patients, and pricing. Ministers have agreed to work toward more consistent assessments of drugs and coverage decisions, and a fair pricing strategy. They will discuss the issue of expensive drugs for rare diseases again at the next health ministers meeting in the fall.